ISoP to host pioneering european seminar on responsible AI in pharmacovigilance
The International Society of Pharmacovigilance (ISoP) will convene its first European Artificial Intelligence Seminar in Basel on 16–17 February 2026, bringing regulators, industry, academics and students together to examine how AI is reshaping drug safety while keeping "humans in the loop". According to the announcement from ISoP, the 1.5‑day in‑person event, themed "AI‑Powered Pharmacovigilance: Humans in the Loop", will combine expert presentations with interactive, case‑based discussions intended to show how AI tools can be applied responsibly across pharmacovigilance processes.
The seminar is designed to address practical applications and regulatory perspectives as AI moves from pilot projects to routine use. ISoP materials describe sessions that will feature leading voices in AI, pharmacovigilance and data science, with an emphasis on real‑world case studies and dialogue between technology developers and safety professionals. According to the original report, this format reflects a sectoral need to reconcile algorithmic efficiency with oversight, explainability and human judgement.
Organisers say the event will also provide regulators and industry with a forum to explore governance and compliance questions as national authorities and international bodies consider policy frameworks for AI in life sciences. Industry data and related event listings highlight a growing calendar of AI‑focused forums for pharmaceuticals and healthcare, suggesting the Basel seminar will sit alongside other international gatherings that aim to harmonise approaches and share best practice.
For practitioners and association executives, the seminar offers networking and professional development opportunities that extend beyond technical talks. ISoP has emphasised interactive workshops and moderated discussions to help delegates translate emerging methodologies into member services, quality systems and pharmacovigilance operations, areas of high interest to trade bodies and confederations seeking to advise and support their members.
Practical information from ISoP notes that special discounted accommodation has been arranged at the HYPERION Hotel Basel, with limited rooms subject to availability, and that reduced fees apply for full‑time students (limited places). The society encourages prospective attendees to contact its support team for further details and registration instructions. According to a related CIOMS newsletter, ISoP has signalled this seminar as a continuation of its recent focus on trustworthy AI in pharmacovigilance.
The Basel seminar forms part of a broader pattern of conferences exploring AI in life sciences and higher education across 2026, including summits in Boston and Paris that convene complementary audiences, from regulators and manufacturers to academic leaders, underscoring the multidisciplinary nature of AI governance and implementation. For associations monitoring sector events, ISoP’s seminar is positioned as a practical, regionally focused opportunity to learn, influence standards and support members through the transition to AI‑enabled pharmacovigilance